Calcium homeostasis in long-term lithium-treated women with bipolar affective disorder.
The authors investigated the effect of long-term lithium administration on intracellular calcium mobilization. The subjects were 13 women with bipolar affective disorder stabilized on lithium and 12 matched healthy controls. Total and ionized serum calcium, intracellular calcium ion concentration, plasma parathyroid hormone (PTH) and tyrotropin (TSH), serum electrolytes and cyclic AMP (cAMP) activity in platelets were measured. The serum electrolytes sodium, potassium and creatinine and plasma PTH and TSH were all within normal ranges in patients and controls and no differences were found between the two groups. No difference was found in basal and prostaglandin E1 (PGE1)-stimulated cAMP generation in platelets between patients and controls. However, total serum calcium and ionized serum calcium levels were higher in patients than in controls and there was a significant correlation between these two measures. In the patient group, serum lithium concentration correlated positively with stimulated levels of intracellular calcium in platelets. In the present study, no distinct hyperparathyroidism was found in lithium-treated patients. However, our findings indicate that lithium administration affects calcium metabolism in patients with bipolar affective disorder inducing mild hypercalcemia and a dose-dependent normalized calcium mobilization. Furthermore, our results did not support the hypothesis that lithium's primary site of action in bipolar illness may be on signal transduction mechanisms.
El Khoury
Aram
A
Department of Psychiatry, Karolinska Institutet, Institution of Clinical Neuroscience, St. Goran's Hospital, Stockholm S-112 81, Sweden. aram.el-khoury@spo.sll.se
Petterson
Ulla
U
Kallner
Gunnar
G
Aberg-Wistedt
Anna
A
Stain-Malmgren
Rigmor
R
D000262:Adenylyl Cyclases / Q000378:metabolism; D000328:Adult; D000331:Aequorin; D001714:Bipolar Disorder / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism*; D001792:Blood Platelets / Q000378:metabolism; D002118:Calcium / Q000378:metabolism*; D002138:Calibration; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D000242:Cyclic AMP / Q000097:blood; D004305:Dose-Response Relationship, Drug; D004573:Electrolytes / Q000097:blood; D005110:Extracellular Space / Q000187:drug effects / Q000378:metabolism; D005260:Female; D006706:Homeostasis / Q000187:drug effects*; D006801:Humans; D008094:Lithium / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D013972:Thyrotropin / Q000097:blood
D004573:Electrolytes; D000331:Aequorin; D013972:Thyrotropin; D008094:Lithium; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D002118:Calcium